Noteworthy, in studies using MCF-7 breast cancer cells, a co-treatment with P4 blocked cyclic adenosine monophosphate and interleukin 1β stimulated aromatase activity [42]. The gene discussed is CYP19A1; the disease is breast carcinoma.